Document is current
Any future updates will be listed below
-
Authors
Grassl, Niklas
Suwala, Abigail K.
Kessler, Tobias
Bunse, Lukas
Mildenberger, Iris
Breckwoldt, Michael O.
Ratliff, Miriam
Brehmer, Stefanie
Herold-Mende, Christel
Etminan, Nima
Wick, Wolfgang
Sahm, Felix
Platten, Michael
Sahm, Katharina https://orcid.org/0000-0001-7694-0988
-
Funding
Funding for this research was provided by:
Deutsches Krebsforschungszentrum (DKFZ)
- License Information
-
More Information
Article History
Received: 5 September 2025
Accepted: 6 October 2025
First Online: 13 January 2026
Declarations
:
: M.P. is founder of Tcelltech and inventor of associated intellectual property related to glioma-reactive T cell receptors (patent no. WO2022200456A1). M.P., K.S. and L.B. are inventors of associated intellectual property related to H3K27M vaccines (patent nos. EP3118217A1 and US20180155403A1). The remaining authors declare no competing interests.
